Peptide Name |
CAT# |
Peptide Sequence |
Amylin (1-13), human |
2027-1-1 |
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala |
Amylin (8-37), human |
2027-1-2 |
Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr |
Amylin (8-37), Human (Free Acid) |
2027-1-3 |
Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr |
Amylin (8-37), rat |
2027-1-4 |
Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 |
Amylin, human, amide |
2027-1-5 |
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 |
Amylin, human, free acid |
2027-1-6 |
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr |
Amylin, rat |
2027-1-7 |
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 |
Peptide Name |
CAT# |
Peptide Sequence |
A-779 |
2027-3-1 |
Asp-Arg-Val-Tyr-Ile-His-D-Ala |
Angiogenin Fragment (108-122) |
2027-3-2 |
Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg |
Angiogenin Fragment (108-123) |
2027-3-3 |
Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg-Pro |
Angiotensin I, human |
2027-3-4 |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu |
Angiotensin II (1-4), human |
2027-3-5 |
Asp-Arg-Val-Tyr |
Angiotensin II (3-8), human |
2027-3-6 |
Val-Tyr-Ile-His-Pro-Phe |
Angiotensin II (4-8), human |
2027-3-7 |
Tyr-Ile-His-Pro-Phe |
Angiotensin II (5-8), human |
2027-3-8 |
Ile-His-Pro-Phe |
Angiotensin II Antipeptide |
2027-3-9 |
Glu-Gly-Val-Tyr-Val-His-Pro-Val |
Angiotensin II, flounder |
2027-3-10 |
Asn-Arg-Val-Tyr-Ile-His-Pro-Phe |
Angiotensin II, human |
2027-3-11 |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe |
Angiotensin III Antipeptide |
2027-3-12 |
Gly-Val-Tyr-Val-His-Pro-Val |
Angiotensin III, human |
2027-3-13 |
Arg-Val-Tyr-Ile-His-Pro-Phe |
Angiotensin, Canine, Rat |
2027-3-14 |
Asp-Arg-Val-Tyr-Ile-His-Pro |
[Ala-Pro-Gly-(Ile3,Val5)] Angiotensin II |
2027-3-15 |
Ala-Pro-Gly-Asp-Arg-Ile-Tyr-Val-His-Pro-Phe |
[Asn1, Val5, Asn9] Angiotensin I, salmon |
2027-3-16 |
Asn-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu |
[Asn1,Val5] Angiotensin II |
2027-3-17 |
Asn-Arg-Val-Tyr-Val-His-Pro-Phe |
[Ile7] Angiotensin III |
2027-3-18 |
Arg-Val-Tyr-Ile-His-Pro-Ile |
[Sar1,Ala8] Angiotensin II |
2027-3-19 |
Sar-Arg-Val-Tyr-Ile-His-Pro-Ala |
[Sar1,Val5, Ala8] Angiotensin II |
2027-3-20 |
Sar-Arg-Val-Tyr-Val-His-Pro-Ala |
[Sar1] Angiotensin II |
2027-3-21 |
Sar-Arg-Val-Tyr-Ile-His-Pro-Phe |
[Val4] Angiotensin III |
2027-3-22 |
Arg-Val-Tyr-Val-His-Pro-Phe |
[Val5] Angiotensin I, human |
2027-3-23 |
Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu |
[Val5] Angiotensin II, human |
2027-3-24 |
Asp-Arg-Val-Tyr-Val-His-Pro-Phe |
